Orbits Oncology is bringing patient insights into the heart of early cancer drug development and personalized medicine. We transform patient tumor data into digital patient surrogates to help cancer researchers make better decisions in drug development and de-risk translation into the clinic. We offer an automated AI software platform for cancer researchers using live-cell imaging techniques to rapidly transform your microscope images into clear analysis reports and graphs with patient-relevant meaning. Whether it is research into drug development, therapy screening, personalized medicine or more, we provide customized platform solutions for your research pipeline so you can accelerate your preclinical and clinical developments.
| Website | http://www.orbits-oncology.com |
| Employees | 8 (3 on RocketReach) |
| Founded | 2023 |
| Industry | Software Development |
| Keywords | Cancer Drug Development, Patient Insights, Personalized Medicine, Early Cancer Detection, Precision Oncology, Patient Data, Oncology Research, Biomarkers, Cancer Research, Drug Development, Cancer Treatment, Data Analytics, Oncology, Clinical Trials, Biotechnology, Pharmaceutical, Medical Technology, Healthcare |
| Competitors | MediMass, ONCOtracker, Inc, Guardant Health, GRAIL, carisls, Foundation Medicine, Genomic Health, Myriad Genetics, Exact Sciences, Roche +44 more (view full list) |
Looking for a particular Orbits Oncology employee's phone or email?
Abraham Lin is the CEO of Orbits Oncology.
3 people are employed at Orbits Oncology.
Orbits Oncology is based in San Francisco, California.